BG43189A3 - Method for preparing of acetylic ester of erythromycine stearate - Google Patents

Method for preparing of acetylic ester of erythromycine stearate

Info

Publication number
BG43189A3
BG43189A3 BG068285A BG6828585A BG43189A3 BG 43189 A3 BG43189 A3 BG 43189A3 BG 068285 A BG068285 A BG 068285A BG 6828585 A BG6828585 A BG 6828585A BG 43189 A3 BG43189 A3 BG 43189A3
Authority
BG
Bulgaria
Prior art keywords
ester
stearate
compound
erythromycin
acetylic
Prior art date
Application number
BG068285A
Other languages
Bulgarian (bg)
English (en)
Inventor
Martti Marvola
Esko Marttila
Jaakko Votila
Aino Pippuri
Pekka Kairisalo
Erkki Honkanen
Original Assignee
Orion- Yhtymae Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion- Yhtymae Oy filed Critical Orion- Yhtymae Oy
Publication of BG43189A3 publication Critical patent/BG43189A3/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Coloring (AREA)
BG068285A 1984-01-06 1985-01-05 Method for preparing of acetylic ester of erythromycine stearate BG43189A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK5884A DK149776C (da) 1984-01-06 1984-01-06 Antibiotisk virksom erytromycinforbindelse og praeparat indeholdende forbindelsen

Publications (1)

Publication Number Publication Date
BG43189A3 true BG43189A3 (en) 1988-04-15

Family

ID=8089251

Family Applications (1)

Application Number Title Priority Date Filing Date
BG068285A BG43189A3 (en) 1984-01-06 1985-01-05 Method for preparing of acetylic ester of erythromycine stearate

Country Status (38)

Country Link
US (1) US4599326A (enExample)
JP (1) JPS60158197A (enExample)
KR (1) KR900006237B1 (enExample)
AT (1) AT386414B (enExample)
AU (1) AU565688B2 (enExample)
BE (1) BE901411A (enExample)
BG (1) BG43189A3 (enExample)
CA (1) CA1224461A (enExample)
CH (1) CH666275A5 (enExample)
CS (1) CS247191B2 (enExample)
CY (1) CY1462A (enExample)
DE (1) DE3500179A1 (enExample)
DK (1) DK149776C (enExample)
ES (1) ES8605818A1 (enExample)
FI (1) FI77249C (enExample)
FR (1) FR2557878B1 (enExample)
GB (1) GB2152502B (enExample)
HK (1) HK11590A (enExample)
HU (1) HU196221B (enExample)
IE (1) IE57967B1 (enExample)
IL (1) IL73885A (enExample)
IS (1) IS2968A7 (enExample)
IT (1) IT1184304B (enExample)
KE (1) KE3841A (enExample)
LU (1) LU85721A1 (enExample)
MA (1) MA20316A1 (enExample)
MX (1) MX156277A (enExample)
NL (1) NL8403979A (enExample)
NO (1) NO160263C (enExample)
NZ (1) NZ210606A (enExample)
PH (1) PH22471A (enExample)
PL (1) PL144349B1 (enExample)
PT (1) PT79777B (enExample)
RO (1) RO91262B (enExample)
SE (1) SE461854B (enExample)
SU (1) SU1410866A3 (enExample)
YU (1) YU44485B (enExample)
ZA (1) ZA8410143B (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4874614A (en) * 1985-03-25 1989-10-17 Abbott Laboratories Pharmaceutical tableting method
US4863741A (en) * 1985-03-25 1989-09-05 Abbott Laboratories Tablet composition for drug combinations
JP3382159B2 (ja) * 1998-08-05 2003-03-04 株式会社東芝 情報記録媒体とその再生方法及び記録方法
WO2004004693A1 (en) * 2002-07-05 2004-01-15 Collgegium Pharmaceutical Abuse-deterrent pharmaceutical compositions of opiods and other drugs
US8840928B2 (en) 2002-07-05 2014-09-23 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
US10004729B2 (en) 2002-07-05 2018-06-26 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
JP2007509975A (ja) * 2003-10-31 2007-04-19 アルザ・コーポレーシヨン ギャバペンチン及びプレギャバリンの増加された吸収のための組成物及び投与形態物
LT1765292T (lt) 2004-06-12 2018-01-10 Collegium Pharmaceutical, Inc. Nuo piktnaudžiavimo apsaugotos vaistų formos
WO2006025882A2 (en) 2004-08-25 2006-03-09 The Uab Research Foundation Absorption enhancers for drug administration
US9895444B2 (en) 2004-08-25 2018-02-20 Aegis Therapeutics, Llc Compositions for drug administration
EP2505189B1 (en) 2006-06-23 2018-08-08 Aegis Therapeutics, LLC Stabilizing alkylglycoside compositions and method thereof
US10668060B2 (en) 2009-12-10 2020-06-02 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
CN103796666B (zh) 2011-05-18 2018-07-06 欧莫德里斯制药公司 改良的肽药物
EP3444281B1 (en) 2012-11-20 2021-11-03 Eumederis Pharmaceuticals, Inc. Improved peptide pharmaceuticals
AU2013347975B2 (en) 2012-11-20 2018-07-26 Mederis Diabetes, Llc Improved peptide pharmaceuticals for insulin resistance
WO2014140699A1 (en) * 2013-03-13 2014-09-18 Calyx Chemicals And Pharmaceuticals Ltd A novel process of liberation of erythromycin and preparation of its salts
FI3155017T3 (fi) 2014-05-28 2024-04-17 Mederis Diabetes Llc Parannettuja peptidilääkkeitä insuliiniresistenssiin
WO2017222575A1 (en) 2016-06-23 2017-12-28 Collegium Pharmaceutical, Inc. Process of making more stable abuse-deterrent oral formulations
KR20200010343A (ko) 2017-05-19 2020-01-30 루넬라 바이오테크 인코포레이티드 안티미토신: 암 줄기 세포를 근절하기 위한 미토콘드리아 생물발생의 표적화 억제제
WO2019108729A1 (en) 2017-12-01 2019-06-06 Lunella Biotech, Inc. Repurposcins: targeted inhibitors of mitochondrial biogenesis for eradicating cancer stem cells
JP6941224B2 (ja) 2018-02-06 2021-09-29 イージス セラピューティクス,エルエルシー 疾患の処置のための鼻腔内エピネフリン製剤及び方法
AU2019217643B2 (en) 2018-02-06 2021-10-28 ARS Pharmaceuticals Operations, Inc. Intranasal epinephrine formulations and methods for the treatment of disease
MX2021007345A (es) * 2018-12-17 2021-07-15 Lunella Biotech Inc Terapias de combinacion triple para fijar como objetivo mitocondrias y aniquilar celulas madre cancerosas.
BR112021011964A2 (pt) * 2018-12-17 2021-09-08 Lunella Biotech, Inc. Terapias de combinação tripla para antienvelhecimento

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1011117B (de) * 1953-11-16 1957-06-27 Abbott Lab Verfahren zur Herstellung von reinen stabilen Erythromycin-Saeure-Additionssalzen
FR1179208A (fr) * 1953-11-16 1959-05-21 Abbott Lab Procédé de préparation de sels d'érythromycine
GB834397A (en) * 1958-07-29 1960-05-04 Lilly Co Eli Therapeutic compositions comprising erythromycin esters
US4150220A (en) * 1977-02-04 1979-04-17 Pfizer Inc. Semi-synthetic 4"-erythromycin A derivatives
FR2473525A1 (fr) * 1980-01-11 1981-07-17 Roussel Uclaf Nouvelles oximes derivees de l'erythromycine, leur procede de preparation et leur application comme medicaments

Also Published As

Publication number Publication date
DK149776B (da) 1986-09-29
YU44485B (en) 1990-08-31
GB2152502B (en) 1987-10-07
IT8519012A0 (it) 1985-01-04
IL73885A0 (en) 1985-03-31
HK11590A (en) 1990-02-23
ZA8410143B (en) 1985-08-28
KR850005452A (ko) 1985-08-26
HU196221B (en) 1988-10-28
MX156277A (es) 1988-08-04
ATA985A (de) 1988-01-15
KE3841A (en) 1989-04-07
GB8432368D0 (en) 1985-02-06
NZ210606A (en) 1987-08-31
IT1184304B (it) 1987-10-28
AU3705984A (en) 1985-07-11
CH666275A5 (de) 1988-07-15
GB2152502A (en) 1985-08-07
ES8605818A1 (es) 1986-04-01
IE57967B1 (en) 1993-06-02
NO160263B (no) 1988-12-19
SU1410866A3 (ru) 1988-07-15
PT79777B (en) 1986-10-21
FR2557878A1 (fr) 1985-07-12
IS2968A7 (is) 1985-04-03
FI77249C (fi) 1989-02-10
FI850023L (fi) 1985-07-07
MA20316A1 (fr) 1985-10-01
LU85721A1 (fr) 1985-07-24
DE3500179A1 (de) 1985-07-18
JPH029040B2 (enExample) 1990-02-28
RO91262B (ro) 1987-07-01
US4599326A (en) 1986-07-08
CS247191B2 (en) 1986-12-18
JPS60158197A (ja) 1985-08-19
FI850023A0 (fi) 1985-01-03
DE3500179C2 (enExample) 1989-08-24
ES539349A0 (es) 1986-04-01
HUT37628A (en) 1986-01-23
PL144349B1 (en) 1988-05-31
KR900006237B1 (ko) 1990-08-27
SE8406671L (sv) 1985-07-07
DK149776C (da) 1987-04-21
IL73885A (en) 1988-10-31
AU565688B2 (en) 1987-09-24
DK5884D0 (da) 1984-01-06
NO160263C (no) 1989-03-29
AT386414B (de) 1988-08-25
CA1224461A (en) 1987-07-21
IE850022L (en) 1985-07-06
SE461854B (sv) 1990-04-02
NL8403979A (nl) 1985-08-01
PT79777A (en) 1985-01-01
FR2557878B1 (fr) 1988-01-15
PH22471A (en) 1988-09-12
YU2085A (en) 1987-12-31
PL251457A1 (en) 1985-11-05
CY1462A (en) 1989-07-21
RO91262A (ro) 1987-06-30
BE901411A (fr) 1985-04-16
SE8406671D0 (sv) 1984-12-28
FI77249B (fi) 1988-10-31
NO850007L (no) 1985-07-08
DK5884A (da) 1985-07-07

Similar Documents

Publication Publication Date Title
BG43189A3 (en) Method for preparing of acetylic ester of erythromycine stearate
DE3650265D1 (de) Makrolide Antibiotika und Verfahren zu deren Herstellung.
SE8406138L (sv) Nya retinoider
RU94042916A (ru) 9a-n - (n'-карбамоил) - и 9a-n - (n'-тиокарбамоил) производные 9-деоксо- 9a - аза - 9a - гомоэтирмицина а, способ их получения и фармкомпозиция на их основе
GB1436978A (en) Choline derivatives and pharmaceutical compositions containing the same
GB1247612A (en) Lincomycin derivatives and the manufacture thereof
SE7707689L (sv) 2-brom-6-fluor-n-2-imidazolidinylidenbensamin dess syraadditionssalter, lekemedel innehallande dessa och forfarande for framstellning derav
SE7903200L (sv) Farmaceutiskt, serskilt diuretiskt verksamt preparat for parenteral administration
NO872574L (no) FremgangsmŸte for fremstilling av terapeutisk aktive tetrahydro-benzotiazoler.
ES418743A1 (es) Un procedimiento para la preparacion del complejo antibio- tico de la butirosina.
ES427433A1 (es) Un procedimiento para preparar un compuesto quimico selec- cionado del grupo que consiste en o-tiocarbamato de nitroi- midazolil-etilo.
SE8402361L (sv) Nya acylaminofenolderivat
SE8701019D0 (sv) Makrolidforening
JPS572298A (en) Erythromycin derivative
NO871187L (no) Fremgangsmaate til fremstilling av en blanding inneholdende indometacin.
GB1463038A (en) Benzhydryloxyalkylamine derivatives and process for the preparation thereof
GB1433977A (en) Acyl derivatives
JPS5432493A (en) Preparation of macrolide antibiotics derivatives
JPS57139015A (en) Remedy for infectious disease for oral administration
SE7707552L (sv) Antibiotikum bl580delta
KR890006643A (ko) β-락탐 항생물질의 모노하이드레이트 및 용매화합물
SU667130A3 (ru) Способ получени соли лизина и -метил-(изопропил-2-инданил-5) уксусной кислоты
JPS57140717A (en) Antidiabetic agent containing o- or m-aminobenzoic acid derivative
GB1397697A (en) Phenoxyalicyclic carboxylic acid derivatives methods of making them and compositions containing them
JPS5687590A (en) Diphosphoglycerine derivative